Prostate Cancer - Results from #24280

Immunotherapy for prostate cancer: Biology and therapeutic approaches - Abstract September 2, 2011

Unusual presentations of metastatic prostate carcinoma as detected by anti-3 F-18 FACBC PET/CT - Abstract September 2, 2011

The changing therapeutic landscape of castration-resistant prostate cancer - Abstract September 2, 2011

Cancer immunology-analysis of host and tumor factors for personalized medicine - Abstract September 2, 2011

PSA affects prostate cancer cell invasion in vitro and induces an osteoblastic phenotype in bone in vivo - Abstract September 2, 2011

Inhibition of Src family kinases and receptor tyrosine kinases by dasatinib: Possible combinations in solid tumors - Abstract September 2, 2011

Multi-media support for informed/shared decision-making before and after a cancer diagnosis - Abstract September 1, 2011

Reirradiation of prostate cancer with rectum preservation: Eradicative high-dose-rate brachytherapy with natural type hyaluronate injection - Abstract September 1, 2011

A novel indium-111-labeled gonadotropin-releasing hormone peptide for human prostate cancer imaging - Abstract September 1, 2011

Use of Surveillance, Epidemiology, and End Results-Medicare data to conduct case-control studies of cancer among the US elderly - Abstract September 1, 2011

Prevalence and correlates of vitamin and supplement usage among men with a family history of prostate cancer - Abstract September 1, 2011

Sunitinib in combination with docetaxel and prednisone in chemotherapy-naive patients with metastatic, castration-resistant prostate cancer: A phase 1/2 clinical trial - Abstract September 1, 2011

The role of C-choline-PET/CT-guided secondary lymphadenectomy in patients with PSA failure after radical prostatectomy: Lessons learned from eight cases - Abstract September 1, 2011

Usefulness of postoperative nadir prostate-specific antigen value by ultrasensitive assay as a predictor of prostate-specific antigen relapse for pathological T3 or positive surgical margins after radical prostatectomy for prostate cancer - Abstract September 1, 2011

Editor's Commentary - Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer September 1, 2011

Editor's Commentary - Projecting the clinical benefits of adjuvant radiotherapy versus observation and selective salvage radiotherapy after radical prostatectomy: A decision analysis September 1, 2011

3-D fiducial motion tracking using limited MV projections in arc therapy - Abstract August 31, 2011

Peritoneal dissemination of prostate cancer due to laparoscopic radical prostatectomy: A case report - Abstract August 31, 2011

Post-translational modification of the androgen receptor - Abstract August 31, 2011

Perineural invasion predicts increased recurrence, metastasis, and death from prostate cancer following treatment with dose-escalated radiation therapy - Abstract August 31, 2011

Page 1215 of 1289